In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.
about
Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexatePerformance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data.Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studiesEvaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial.Randomized controlled trial of a nurse-led rheumatology clinic for monitoring biological therapy.A customized protocol to assess bone quality in the metacarpal head, metacarpal shaft and distal radius: a high resolution peripheral quantitative computed tomography precision studyEfficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial.Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial.Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexateAssessment of synovitis to predict bone erosions in rheumatoid arthritis.Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trialAn evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression.Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort.Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial.Goals for rheumatoid arthritis: treating to target or treating to prevent?IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide.Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis.A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate FailureInfliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial.Cost-Effectiveness Model for Evaluating New Diagnostic Tests in the Evaluation of Patients With Inflammatory Arthritis at Risk of Having Rheumatoid Arthritis.Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.A randomized, double-blind, sham-controlled study of static electric field therapy by high voltage alternating current for active rheumatoid arthritis.Disability is the major negative predictor for achievement of Boolean-based remission in patients with rheumatoid arthritis treated with tocilizumab.Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis.Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study).Denosumab, cortical bone and bone erosions in rheumatoid arthritis.First-year radiographic progression as a predictor of further progression in early arthritis: results of a large national French cohort.Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis.Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort.
P2860
Q24658507-314486EF-C2C1-4C0B-8F4D-6C5D549DBD98Q31104875-90D95041-C712-42EF-89EE-08BFADD3AEEAQ33578361-5BD3B27F-7058-43F4-8348-564FEB03D8F0Q34622578-0AFA1AFB-9904-4C78-B423-77E2EF15C953Q34850808-B8B1EAAF-E3CF-409B-A882-BF997C9AF4C4Q35074535-A2891FFB-2A09-447F-BDF0-0ECC635F7193Q35084199-4AB94FB3-E6FD-4EE1-A80B-3C1B919A9FC6Q35605424-B006C51A-F618-45B0-9E1C-4DF01AFDAD8EQ35792901-747EB89A-79FE-4362-A159-82F165AA317BQ35891851-7E2750B4-F672-47A4-AEC0-FBFBF3765B6EQ36027446-9C32F2F3-9DAE-428F-9475-21B3866E014EQ36111299-3D28D881-3951-4DF8-9B4F-9EE88B6D3388Q36657901-9335E7CD-67B5-4588-9C29-C8BFE796A273Q36778521-D82E94B5-B4FF-4649-83A5-B9BC2CC5FCEFQ36907694-0869F8A2-7348-4DBC-B5AA-A327D9CF8D2BQ36960366-21F38A40-6C00-4D96-9FD1-5F3BBE85D576Q37301156-702F8613-930B-47D4-938C-A3DECB0DA503Q37602033-56B2046D-98B4-428E-8C26-BB1B158B8538Q38024758-685D5A8C-EA0C-448A-A3DF-3762DA34C5CBQ39088676-3B38E4E3-52F3-4CE8-9AE7-A4C21FB1BEAFQ39888893-579C72B2-4583-48C5-A6CE-F60D2AD1A33AQ40337291-BDC69AE7-C85C-4A1D-B1AD-86641F288178Q41927602-893A076E-FF12-4188-B202-BAF9068C6AE2Q43101622-C895B580-A5A1-4588-99A8-7F8C9AE3E4AAQ43752980-13DB6BA4-45EC-491E-AC91-B827BE37D76CQ46288657-F91DEA79-D2BC-4460-9FAA-69C99111B776Q46605974-FC1498C3-7C66-4AC1-AF7A-F4BA8F976AB5Q48187901-0F74F7D2-29FD-4B1B-BCD0-2AC056C8B291Q51220135-88F1F17F-DE9A-4D74-BBC1-F7C6CFBD2090Q55267199-D2D74FC1-F024-4D52-8041-270215C94466Q55512246-FB8EB247-26A4-4E92-8BFE-4E4AD5893E15
P2860
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
In early rheumatoid arthritis, ...... opulation in the SWEFOT trial.
@ast
In early rheumatoid arthritis, ...... opulation in the SWEFOT trial.
@en
In early rheumatoid arthritis, ...... opulation in the SWEFOT trial.
@nl
type
label
In early rheumatoid arthritis, ...... opulation in the SWEFOT trial.
@ast
In early rheumatoid arthritis, ...... opulation in the SWEFOT trial.
@en
In early rheumatoid arthritis, ...... opulation in the SWEFOT trial.
@nl
prefLabel
In early rheumatoid arthritis, ...... opulation in the SWEFOT trial.
@ast
In early rheumatoid arthritis, ...... opulation in the SWEFOT trial.
@en
In early rheumatoid arthritis, ...... opulation in the SWEFOT trial.
@nl
P2093
P1476
In early rheumatoid arthritis, ...... opulation in the SWEFOT trial.
@en
P2093
Hamed Rezaei
Helena Wallin
Ingemar F Pettersson
Johan Bratt
Kristina Albertsson
Kristina Forslind
Pierre Geborek
Saedis Saevarsdottir
Sofia Ernestam
P304
P356
10.1136/ANNRHEUMDIS-2011-200038
P407
P577
2011-09-19T00:00:00Z